Mersana Therapeutics Inc (NASDAQ:MRSN) shares, rose in value on Wednesday, April 16, with the stock price down by -3.64% to the previous day’s close as strong demand from buyers drove the stock to $0.34.
Actively observing the price movement in the last trading, the stock closed the session at $0.35, falling within a range of $0.3134 and $0.3591. The value of beta (5-year monthly) was 1.665. Referring to stock’s 52-week performance, its high was $3.83, and the low was $0.26. On the whole, MRSN has fluctuated by -28.42% over the past month.
With the market capitalization of Mersana Therapeutics Inc currently standing at about $41.85 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-02.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 6.05M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MRSN’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of MRSN currently trading nearly -4.59% and -28.97% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 41.25, while the 7-day volatility ratio is showing 15.96% which for the 30-day chart, stands at 13.30%. Furthermore, Mersana Therapeutics Inc (MRSN)’s beta value is 1.31, and its average true range (ATR) is 0.05.
A comparison of Mersana Therapeutics Inc (MRSN) with its peers suggests the former has fared considerably weaker in the market. MRSN showed an intraday change of -3.64% in last session, and over the past year, it shrunk by -91.14%%.
Data on historical trading for Mersana Therapeutics Inc (NASDAQ:MRSN) indicates that the trading volumes over the past 10 days have averaged 2.65 and over the past 3 months, they’ve averaged 4.45 million. According to company’s latest data on outstanding shares, there are 115.65 million shares outstanding.
Nearly 31.15% of Mersana Therapeutics Inc’s shares belong to company insiders and institutional investors own 54.65% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 9.68 million shares as on 2025-03-31, resulting in a short ratio of 2.95. According to the data, the short interest in Mersana Therapeutics Inc (MRSN) stood at 1016.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 10.32 million. The stock has fallen by -76.52% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MRSN stock heading into the next quarter.
